Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations

Author:

Wolfgang Aaron S.ORCID,Hoge Charles W.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Reference128 articles.

1. •• Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021. https://doi.org/10.1038/s41591-021-01336-3. This randomized, double-blind, placebo-controlled, clinical trial of MDMA-AT for PTSD was the first phase 3 study of any PAT. It found a large effect size of improvement in PTSD symptom outcomes after 3 sessions of MDMA-AT.

2. • Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiat. 2021;78(5):481–9. https://doi.org/10.1001/jamapsychiatry.2020.3285. This randomized, waitlist-controlled clinical trial characterized improvements in depression after 2 sessions of psilocybin-assisted therapy.

3. •• Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387(18):1637–48. https://doi.org/10.1056/NEJMoa2206443. This is currently the largest PAT clinical trial conducted to date. It found significant improvements in depression outcomes after a single session of psilocybin-assisted therapy.

4. • Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, et al. Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiat. 2022. https://doi.org/10.1001/jamapsychiatry.2022.2096. This is currently the largest randomized, double-blind, placebo-controlled clinical trial of psilocybin-assisted therapy for alcohol use disorder. It found significant improvements in drinking-related outcomes after 2 sessions of psilocybin-assisted therapy.

5. Grinspoon L, Bakalar JB. Psychedelic reflections. University of California: Human Sciences Press; 1983.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3